Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.

Los Angeles, CA, March 25, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (ENDV) (“Endonovo” or the “Company”) today announces the

Read more